Try our Advanced Search for more refined results
Health - April, 2005
33 articles
- Axis-Shield, CTT Settle Patent Dispute Over Homocysteine Assays
- Judge OKs Glaxo's $65M Settlement Of Antitrust Suit Over Paxil Patent Gaming
- Lilly Sues Teva To Block Generic Symbyax
- Quidel To Pay $17M To Settle Inverness Patent Dispute
- Medtronic Settles Patent Dispute With Cytomedix
- FTC Asks 11th Circuit To Rehear Suit Vs. Schering
- Medtronic To Pay Doctor $1.4B To End Patent Dispute
- Altana, Wyeth Sue Sun Pharma Over Protonix ANDA
- Merck Loses Bid For En Banc Rehearing In Fosamax Patent Case
- European Ruling Could Slash Marketing Exclusivity
- Supreme Court Questions Limited Scope Of Patent Liability Exemption
- European Generic Makers Wary Of Marketing Exclusivity For Pediatric Testing
- Judge Dismisses Tercica, Genentech Patent Suit Vs. Insmed
- Landmark Case To Test Research Exemption To Patent Liability
- Dr. Reddy's, Ivax to Appeal Zyprexa Patent Decision
- Judge Upholds Zyprexa Patent
- Medtronic Infringes Biomet Patent, California Court Rules
- Delaware Court Consolidates, Postpones Trial In Adderall XR Patent Challenge
- Barr Gets FDA Green Light For Allegra-D Amid Patent Dispute
- Kos, Barr Settle Niaspan Patent Litigation With Unusual Deal
- U.S. District Court To Issue Ruling In Zyprexa Case Thursday
- Merck Sues Canadian Online Pharmacies Over Zocor Sales
- Federal Circuit Rules For Tyco Unit In Patent Suit Vs. Masimo
- Shire Opts Not To Sue Teva Over Adderall XR ANDA
- Barr Drops Suit Vs. FDA Over Allegra Marketing Exclusivity
- Federal Circuit Dismisses Apotex Suit V. Pfizer Over Accupril Patent
- Glaxo Loses Paxil Suit At Federal Circuit
- FTC Says Ivax Misconstrues Hatch-Waxman Rules
- New Venture To Hold Broad Patent Rights To Cloning Technologies
- Judge Compels Glaxo CEO To Answer Questions In Challenge To AZT Patent
- Japanese Patent Office Invalidates Applera Patent
- In Blow To Teva, Federal Circuit Refuses To Rehear Zoloft Patent Case
- Barr Granted Summary Judgment On Another Patent In Allegra Challenge